Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Reckitt Benckiser Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT01677377
First received: August 27, 2012
Last updated: September 6, 2013
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)